SILO
SILO
NASDAQ · Biotechnology

Silo Pharma Inc

$3.22
+0.13 (+4.04%)
Financial Highlights (FY 2026)
Revenue
10.5K
Net Income
-614,540
Gross Margin
38.6%
Profit Margin
-5,863.7%
Rev Growth
+1.0%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 38.6% 38.5% 63.9% 63.9%
Operating Margin -5,992.5% -5,393.4% 18.2% 20.0%
Profit Margin -5,863.7% -5,570.5% 17.8% 16.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 10.5K 10.4K 653.1K 554.3K
Gross Profit 4.0K 4.0K 417.2K 354.1K
Operating Income -627,832 -559,509 118.9K 110.9K
Net Income -614,540 -547,664 116.0K 91.5K
Gross Margin 38.6% 38.5% 63.9% 63.9%
Operating Margin -5,992.5% -5,393.4% 18.2% 20.0%
Profit Margin -5,863.7% -5,570.5% 17.8% 16.5%
Rev Growth +1.0% +1.0% -9.1% -7.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 583.1K 550.9K
Total Equity 1.94M 1.85M
D/E Ratio 0.30 0.30
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -627,942 -590,696 172.6K 151.1K
Free Cash Flow 101.3K 71.5K